The Enterprise Value as of December 2024 (TTM) for Pieris Pharmaceuticals, Inc. (PIRS) is -1407736.00

According to Pieris Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1407736.00. This represents a change of 23.25% compared to the average of -1142196.96 of the last 4 quarters.

Pieris Pharmaceuticals, Inc. (PIRS) Historical Enterprise Value (quarterly & annually)

How has PIRS Enterprise Value performed in the past?

The mean historical Enterprise Value of Pieris Pharmaceuticals, Inc. over the last ten years is 93.73M. The current -1407736.00 Enterprise Value has changed -250.19% with respect to the historical average. Over the past ten years (40 quarters), PIRS's Enterprise Value was at its highest in in the June 2022 quarter at 11.05B. The Enterprise Value was at its lowest in in the June 2023 quarter at -17605738.88.

Pieris Pharmaceuticals, Inc. (PIRS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pieris Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pieris Pharmaceuticals, Inc. (PIRS) Average Enterprise Value

How has PIRS Enterprise Value performed in the past?

The current Enterprise Value of Pieris Pharmaceuticals, Inc. (PIRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pieris Pharmaceuticals, Inc. (PIRS) Enterprise Value vs. Peers

How is PIRS’s Enterprise Value compared to its peers?

Pieris Pharmaceuticals, Inc.’s Enterprise Value is less than Adaptimmune Therapeutics plc (58.35M), less than Mereo BioPharma Group plc (445.16M), less than PDS Biotechnology Corporation (37.39M), less than Leap Therapeutics, Inc. (48.29M), less than X4 Pharmaceuticals, Inc. (79.21M), less than Corvus Pharmaceuticals, Inc. (288.04M), less than Terns Pharmaceuticals, Inc. (234.86M), less than TCR2 Therapeutics Inc. (79.12M), less than Affimed N.V. (22.91M), less than ADC Therapeutics SA (249.65M), less than Agenus Inc. (74.19M), less than Inozyme Pharma, Inc. (215.58M), greater than Achilles Therapeutics plc (-42104641.00), less than Checkpoint Therapeutics, Inc. (165.69M), less than Cue Biopharma, Inc. (42.98M), less than Medicenna Therapeutics Corp. (113.60M),

Build a custom stock screener for Pieris Pharmaceuticals, Inc. (PIRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pieris Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pieris Pharmaceuticals, Inc. (PIRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pieris Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.